Department of obstetrics and gynecology, Qinhuangdao Maternal and Child Health Hospital, Qinhuangdao, Hebei, China.
Department of Neurology, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, China.
Medicine (Baltimore). 2023 Dec 15;102(50):e36707. doi: 10.1097/MD.0000000000036707.
This study aimed to identify the key genes involved in the development of endometriosis and construct an accurate predictive model to provide new directions for the diagnosis and treatment of endometriosis. Using bioinformatics analysis, we employed the single-cell cell communication method to identify the key cell subtypes. By combining chip data and integrating differential analysis, WGCNA analysis, and the least absolute shrinkage and selection operator (LASSO) model, key genes were identified for immune infiltration and functional enrichment analyses. Cell communication analysis identified tissue stem cells as the key subtype. Differential analysis revealed 1879 differentially expressed genes, whereas WGCNA identified 357 module genes. The LASSO model further selects 4 key genes: Adipocyte Enhancer Binding Protein 1(AEBP1), MBNL1, GREM1, and DES. All 4 key genes showed significant correlations with immune cell content. Moreover, these genes were significantly expressed in single cells. The predictive model demonstrated good diagnostic performance. Through scRNA-seq, WGCNA, and LASSO methodologies, DES, GREM1, MBNL1, and AEBP1 emerged as crucial core genes linked to tissue stem cell markers in endometriosis. These genes have promising applications as diagnostic markers and therapeutic targets for endometriosis.
本研究旨在鉴定子宫内膜异位症发生发展过程中的关键基因,并构建准确的预测模型,为子宫内膜异位症的诊断和治疗提供新方向。我们采用单细胞细胞通讯方法,通过生物信息学分析,鉴定关键细胞亚型。结合芯片数据,通过差异分析、WGCNA 分析和最小绝对收缩和选择算子(LASSO)模型,鉴定关键基因进行免疫浸润和功能富集分析。细胞通讯分析将组织干细胞鉴定为关键亚型。差异分析显示 1879 个差异表达基因,而 WGCNA 鉴定了 357 个模块基因。LASSO 模型进一步选择 4 个关键基因:脂肪细胞增强结合蛋白 1(AEBP1)、MBNL1、GREM1 和 DES。所有 4 个关键基因均与免疫细胞含量呈显著相关。此外,这些基因在单细胞中表达显著。预测模型表现出良好的诊断性能。通过 scRNA-seq、WGCNA 和 LASSO 方法,DES、GREM1、MBNL1 和 AEBP1 成为与子宫内膜异位症组织干细胞标志物相关的关键核心基因。这些基因有望成为子宫内膜异位症的诊断标志物和治疗靶点。